𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Reduction of phosphodiesterase 3B gene expression in peroxisome proliferator-activated receptor γ (+/−) mice independent of adipocyte size

✍ Scribed by Takahiro Ogura; Haruhiko Osawa; Yan Tang; Hiroshi Onuma; Masaaki Ochi; Tatsuya Nishimiya; Naoto Kubota; Yasuo Terauchi; Takashi Kadowaki; Hideichi Makino

Book ID
117105324
Publisher
Elsevier Science
Year
2003
Tongue
English
Weight
105 KB
Volume
542
Category
Article
ISSN
0014-5793

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Decreased expression of peroxisome proli
Decreased expression of peroxisome proliferator activated receptor γ in CFTR−/− mice
✍ Mario Ollero; Omer Junaidi; Munir M. Zaman; Iphigenia Tzameli; Adolfo A. Ferrand 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 472 KB 👁 1 views

Some of the pathological manifestations of cystic fibrosis are in accordance with an impaired expression and/or activity of PPARgamma. We hypothesized that PPARgamma expression is altered in tissues lacking the normal cystic fibrosis transmembrane regulator protein (CFTR). PPARgamma mRNA levels were

Thiazolidinediones inhibit hepatocarcino
Thiazolidinediones inhibit hepatocarcinogenesis in hepatitis B virus–transgenic mice by peroxisome proliferator-activated receptor γ–independent regulation of nucleophosmin
✍ Andrea Galli; Elisabetta Ceni; Tommaso Mello; Simone Polvani; Mirko Tarocchi; Fr 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 907 KB

Antidiabetic thiazolidinediones (TZD) have in vitro antiproliferative effect in epithelial cancers, including hepatocellular carcinoma (HCC). The effective anticancer properties and the underlying molecular mechanisms of these drugs in vivo remain unclear. In addition, the primary biological target